C-Reactive Protein (CRP)
Females, Age 60-69
The median C-reactive protein (CRP) for US females aged 60-69 is 2.2 mg/L, with 90% of the population falling between 0.41 mg/L and 12.42 mg/L.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 740 participants · Unit: mg/L
Percentile Distribution
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (mg/L) | 0.4 | 0.5 | 0.9 | 2.2 | 5 | 8.5 | 12.4 |
| 95% CI | 0.3 | 0.4 | 0.7 | 1.6 | 4.2 | 7 | 10 |
| Percentile | Value (mg/L) | 95% CI |
|---|---|---|
| P5 | 0.4 | 0.3 |
| P10 | 0.5 | 0.4 |
| P25 | 0.9 | 0.7 |
| P50 | 2.2 | 1.6 |
| P75 | 5 | 4.2 |
| P90 | 8.5 | 7 |
| P95 | 12.4 | 10 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
0.9 2.2 5
P25 P50 P75
P5 0.4 P95 12.4
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from full MEC sample using NHANES hs-CRP assay)
- Survey years
- 2017-2020
- Measurement
- Measured by high-sensitivity latex-enhanced immunoturbidimetric assay on Roche Cobas 6000 (c501 module). How it was measured
- Sample size
- 740 participants
- Reference population
- US civilian non-institutionalized females aged 60-69 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing high-sensitivity CRP measurement (LBXHSCRP)
- Missing or zero MEC sample weight (WTMEC)
- Age outside 60-69 range
- Notes
- Percentiles computed using the combined pre-pandemic MEC weight (WTMECPRP). CRP measured as high-sensitivity CRP (LBXHSCRP) in mg/L.